Protein Kinase D3 Promotes the Reconstruction of OSCC Immune Escape Niche Via Regulating MHC-I and Immune Inhibit

Die Lv1, Jiao Chen, Yingzhu Kang

  • 1State Key Laboratory of Oral Diseases, National Clinical Research Center for Oral Diseases, West China Hospital of Stomatology, Sichuan University, Chengdu, Sichuan Province, People's Republic of China.

Insights

Protein kinase D3 (PKD3) promotes oral cancer immune escape by altering immune-related molecules like PD-L1 and MHC-I. This impacts the tumor microenvironment and T cell responses, highlighting PKD3 as a potential therapeutic target.

Area of Science:

  • Oncology
  • Immunology
  • Molecular Biology

Background:

  • Protein kinase D3 (PKD3) is implicated in various cancers.
  • Its role in tumor immune escape, particularly in oral squamous cell carcinoma (OSCC), is largely unexplored.

Purpose of the Study:

  • To investigate the function and mechanism of PKD3 in shaping the immune escape niche of OSCC.
  • To determine PKD3's impact on key immune regulatory molecules within the tumor microenvironment.

Main Methods:

  • Western blotting analysis of OSCC cells.
  • Gene expression correlation analysis using The Cancer Genome Atlas (TCGA) data.
  • PKD3 knockdown and overexpression experiments in OSCC and precancerous cells.
  • Measurement of cytokine secretion.
  • T lymphocyte activation assays.

Main Results:

  • PKD3 expression positively correlated with Fas and PD-L1, and negatively with MHC-I in OSCC.
  • PKD3 knockdown decreased Fas and PD-L1, increased MHC-I, and reduced secretion of TGF-β, CCL21, and IL-10.
  • PKD3 overexpression showed opposite effects.
  • Tumor antigens from PKD3-knockdown cells enhanced T lymphocyte growth and activation.

Conclusions:

  • PKD3 promotes OSCC immune escape by modulating Fas, PD-L1, MHC-I, TGF-β, CCL21, and IL-10.
  • PKD3 plays a critical role in reconstructing the tumor immune escape niche.
  • Targeting PKD3 may offer a strategy to overcome immune evasion in OSCC.

Related Concept Videos

The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...
9.6K
PI3K/mTOR/AKT Signaling Pathway01:22

PI3K/mTOR/AKT Signaling Pathway

The mammalian target of rapamycin  (mTOR) is a serine/threonine kinase that regulates growth, proliferation, and cell survival in response to hormones, growth factors, or nutrient availability. This kinase exists in two structurally and functionally distinct forms: mTOR complex 1  (mTORC1) and mTOR complex 2  (mTORC2). The first form (mTORC1) is composed of a rapamycin-sensitive Raptor and proline-rich Akt substrate, PRAS40. In contrast,  mTORC2 consists of a...
4.2K
mTOR Signaling and Cancer Progression03:03

mTOR Signaling and Cancer Progression

The mammalian target of rapamycin or mTOR protein was discovered in 1994 due to its direct interaction with rapamycin. The protein gets its name from a yeast homolog called TOR. The mTOR protein complex in mammalian cells plays a major role in balancing anabolic processes such as the synthesis of proteins, lipids, and nucleotides and catabolic processes, such as autophagy in response to environmental cues, such as availability of nutrients and growth factors.
The mTOR pathway or the...
3.9K
Receptor Downregulation in MVBs01:15

Receptor Downregulation in MVBs

Multivesicular bodies (MVBs) are mature endosomes that sort ubiquitinated proteins and then fuse with lysosomes to degrade the sorted proteins. Epidermal growth factor (EGF) and its receptor (EGFR) form a complex that can be internalized through endocytosis, sorted into an MVB, and later degraded.
The EGFR can initiate signaling pathways that  lead to cell proliferation, migration, and differentiation. Overexpression of EGFR  stimulates cells to proliferate. Excessive  EGFR...
2.3K
Interactions Between Signaling Pathways01:19

Interactions Between Signaling Pathways

Signaling cascades usually lack linearity. Multiple pathways interact and regulate one another, allowing cells to integrate and respond to diverse environmental stimuli.
Convergence and divergence, and cross-talk between signaling pathways
Two distinct signaling pathways can converge on a single functional unit, which may either be a single protein or a complex of proteins. The response is either functionally distinct or synergistic between the two pathways but different from the response...
6.7K
Abnormal Proliferation02:23

Abnormal Proliferation

Under normal conditions, most adult cells remain in a non-proliferative state unless stimulated by internal or external factors to replace lost cells. Abnormal cell proliferation is a condition in which the cell's growth exceeds and is uncoordinated with normal cells. In such situations, cell division persists in the same excessive manner even after cessation of the stimuli, leading to persistent tumors. The tumor arises from the damaged cells that replicate to pass the damage to the...
4.7K